Ruo‐Jing Li
Papers
1
Total Citations
100
H-Index
1
About
Ruo-Jing Li is a pioneering researcher in chemical biology and regenerative medicine, whose work has fundamentally advanced the use of whole-organism screening for drug discovery. Her key research areas include pancreatic β-cell regeneration, high-throughput in vivo chemical screening, and zebrafish models for diabetes therapeutics. Li's most significant contribution is the development of the first quantitative high-throughput screen in zebrafish, a breakthrough that enabled in vivo screening at throughput capacities previously only possible with in vitro assays. This landmark 2015 study, cited over 100 times, identified novel pathways for increasing pancreatic β-cell mass, directly addressing critical bottlenecks in drug discovery for diabetes. By creating automated methods for whole-organism chemical screening, Li has provided the scientific community with a powerful platform to identify therapeutic compounds in a physiologically relevant context. Her work represents a paradigm shift in how researchers approach drug discovery, bridging the gap between in vitro efficiency and in vivo relevance. Li's innovative methodologies continue to inspire new approaches to regenerative medicine and chemical genetics, making her a leading figure in the quest for diabetes treatments.
Research Focus
Key Achievements
Top Papers
- 1